SCHEMBL21883787

SCHEMBL21883787

CCN[C@@H](CCc1ccccc1)C(=O)N[C@@H](COC)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.50
▸ CA12 O43570 1/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ CA3 P07451 1/20 0.47
▸ CA4 P22748 1/20 0.47
▸ CA6 P23280 1/20 0.47
▸ CA5A P35218 1/20 0.47
▸ CA7 P43166 1/20 0.47
▸ CACNA1C Q13936 1/20 0.47
▸ SCN9A Q15858 1/20 0.47
▸ CA9 Q16790 1/20 0.47
▸ CA13 Q8N1Q1 1/20 0.47
▸ CA14 Q9ULX7 1/20 0.47
▸ CA5B Q9Y2D0 1/20 0.47
▸ ACE P12821 4/20 0.46
▸ MME P08473 2/20 0.46
▸ CPA1 P15085 1/20 0.46
▸ ACE2 Q9BYF1 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20431098 0.88 ALDH1A1 (0.48) ALDH1A1CA12CA1CA2CA3
SCHEMBL20431079 0.86 ALDH1A1 (0.49) ALDH1A1CA12CA1CA2CA3
SCHEMBL2208433 0.84 MME (0.55) ACEMMECPA1ACE2SMN1; SMN2
SCHEMBL2208436 0.84 MME (0.55) ACEMMECPA1ACE2SMN1; SMN2
SCHEMBL22472895 0.83 LNPEP (0.53) ALDH1A1CA12CA1CA2CA3
SCHEMBL18942459 0.79 ALDH1A1 (0.49) ALDH1A1CA12CA1CA2CA3
SCHEMBL10659142 0.78 KDM4E (0.56) ALDH1A1CA12CA1CA2CA3
SCHEMBL10659140 0.78 KDM4E (0.56) ALDH1A1CA12CA1CA2CA3
SCHEMBL21883816 0.77 ACE (0.39) ALDH1A1CA12CA1CA2CA3
SCHEMBL10659451 0.77 CTSK (0.53) CA12CA1CA2CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200087343-A1 EPOXYKETONE COMPOUNDS FOR ENZYME INHIBITION CENTRAX INTERNATIONAL, INC. (US) 2020-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200087343-A1 EPOXYKETONE COMPOUNDS FOR ENZYME INHIBITION PSMD10, PSMC1, PSMB10 ALDH1A1 1707/4885CA12 4639/4885CA1 4078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback